JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $167,238 | +799.8% | 90,399 | +439.9% | 0.00% | – |
| Q4 2022 | $18,586 | -99.5% | 16,744 | -98.8% | 0.00% | -100.0% |
| Q3 2022 | $3,407,000 | -33.7% | 1,455,862 | -14.1% | 0.00% | 0.0% |
| Q2 2022 | $5,136,000 | -56.0% | 1,694,867 | -1.3% | 0.00% | -50.0% |
| Q1 2022 | $11,664,000 | -19.2% | 1,717,754 | -0.7% | 0.00% | -33.3% |
| Q4 2021 | $14,438,000 | +11.8% | 1,729,036 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $12,913,000 | -10.9% | 1,737,951 | -18.5% | 0.00% | 0.0% |
| Q2 2021 | $14,492,000 | -36.8% | 2,131,201 | -4.6% | 0.00% | -50.0% |
| Q1 2021 | $22,942,000 | +70.8% | 2,233,847 | +16.4% | 0.01% | +100.0% |
| Q4 2020 | $13,436,000 | +1102.9% | 1,919,549 | +1302.9% | 0.00% | – |
| Q3 2020 | $1,117,000 | -66.4% | 136,825 | -71.6% | 0.00% | -100.0% |
| Q2 2020 | $3,326,000 | +784.6% | 481,902 | +507.3% | 0.00% | – |
| Q1 2020 | $376,000 | -35.7% | 79,346 | +18.4% | 0.00% | – |
| Q4 2019 | $585,000 | +1525.0% | 67,016 | +528.1% | 0.00% | – |
| Q3 2019 | $36,000 | -80.0% | 10,669 | -70.7% | 0.00% | – |
| Q2 2019 | $180,000 | -63.1% | 36,404 | -53.8% | 0.00% | – |
| Q1 2019 | $488,000 | +67.1% | 78,713 | -9.1% | 0.00% | – |
| Q4 2018 | $292,000 | -81.3% | 86,558 | -63.9% | 0.00% | -100.0% |
| Q3 2018 | $1,560,000 | -64.4% | 239,930 | -58.0% | 0.00% | -50.0% |
| Q2 2018 | $4,380,000 | -33.0% | 571,771 | +95.4% | 0.00% | -50.0% |
| Q1 2018 | $6,539,000 | +3169.5% | 292,585 | +1953.9% | 0.00% | – |
| Q2 2017 | $200,000 | – | 14,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |